TGFB1 and neoplasm: Senzer and colleagues recently described a novel FANG vaccine whereby autologous whole tumor cells are being genetically engineered to express GM-CSF via a plasmid and a bifunctional short hairpin RNAi (bi-shRNAi) to target furin convertase to downregulate endogenous TGF-β1 and -β2 [45].